0.00Open0.10Pre Close0 Volume14 Open Interest12.50Strike Price0.00Turnover90.53%IV29.45%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0542Delta0.0276Gamma175.75Leverage Ratio-0.0093Theta-0.0006Rho-9.52Eff Leverage0.0048Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet